Navigation Links
Study Finds Taxus(R) Drug-Eluting Stent Beneficial in Treatment of Large Vessels
Date:4/1/2008

Results from TAXUS IV and V randomized clinical trials favor DES compared

to bare-metal stents

NATICK, Mass. and CHICAGO, April 1, 2008 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today welcomed favorable outcomes of one- year data from the Company's TAXUS IV and V randomized clinical trials in patients who received the TAXUS(R) Express(TM) Paclitaxel-Eluting Coronary Stent System compared to patients who received bare-metal stents (BMS). These results add to the growing body of evidence that paclitaxel-eluting stents are clinically beneficial over BMS even in the treatment of large vessels (greater than 3.5 mm), which typically have reduced restenosis risk compared to smaller diameter vessels. David A. Cox, M.D., FACC, presented the TAXUS IV and V results at the SCAI Annual Scientific Sessions in Partnership with the ACC/i2 Summit in Chicago.

In an analysis of TAXUS IV and V one-year clinical events, Dr. Cox reported that patients treated with the TAXUS Stent had significant reductions in one-year revascularization rates in both large and small diameter vessels compared to BMS. Although the absolute magnitude of the efficacy benefit was reduced in large diameter vessels, the relative reduction compared to BMS was maintained.

Results include outcomes from 2,458 patients divided into three groups according to maximal device diameter (defined as the diameter of the largest final stent or post-dilatation balloon utilized): <3.5 mm (n=1,528 patients), >/=3.5mm-<4.0mm (n=655), and >/=4.0mm (n=275). Compared to BMS, patients treated with the TAXUS Stent had lower rates of target lesion revascularization (TLR) at all device diameters: 9.7% vs. 20.4% (p<0.001) for <3.5mm, 4.5%
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
2. Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
3. Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder
4. Large Study Gives Nod to Drug-Eluting Stents in Heart Attack
5. Study Finds Repeated Episodes of Stent Thrombosis Common
6. Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery
7. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
8. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
9. St. Jude Study Offers New Hope for Children With Kidney Tumors Deemed Inoperable
10. Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan
11. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... and FLORHAM PARK, N.J. , ... once-daily naldemedine met its primary and secondary endpoints in ... of opioid-induced constipation (OIC) in adult patients with chronic ... mu-opioid receptor antagonist (PAMORA). This is the third Phase ... key secondary endpoints. Study results showed that ...
(Date:8/3/2015)... BOULDER, Colo., Aug. 3, 2015  Encision Inc. (PK:ECIA), ... prevents dangerous stray electrosurgical burns in minimally invasive surgery, ... quarter that ended June 30, 2015. The ... a quarterly net loss of $213 thousand, or $(0.02) ... $2.476 million for a net loss of $202 thousand, ...
(Date:8/3/2015)... DIEGO , Aug. 3, 2015  Sorrento Therapeutics, ... it has entered into an exclusive licensing agreement to ... biobetter antibodies from Mabtech Limited, a holding company for ... China . Under the terms ... 4 monoclonal antibodies (mAbs) for the North American, European ...
Breaking Medicine Technology:Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 2Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 4
... spine can happen for any number of reasons, whether it,s ... old age, or blunt injury. Unfortunately, people who have experienced ... back braces, reduced mobility, and elongated periods of pain and ... patients are able to restore proper function to the spine ...
... 17, 2011 Zen Holding Corp. (Symbol: ZNHL) today ... name change to Millennium HealthCare Inc.  The Company will ... change as well. About Zen Holding Corp. ... company that operates thru its wholly-owned subsidiaries Greenleaf Management ...
Cached Medicine Technology:Dr. Seyed M. Rezaian's Spinal Fixator a Revolutionary Invention for Healing Injuries of the Thoracolumbar Spine 2Zen Holding Corp. Changes Name to Millennium HealthCare Inc. 2
(Date:8/3/2015)... ... August 03, 2015 , ... ... research organisations (CROs) for a slew of benefits, allowing them to gain access ... boost quality with cost-effective utilisation of resources, get access to innovation and ensure ...
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... ... services to help patients in need. Most people know that general health emergencies, such ... Unfortunately, a fewer amount of people know where to turn to during a dental ...
(Date:8/3/2015)... ... August 03, 2015 , ... AxoGen, Inc. (NASDAQ: AXGN), ... scheduled to present at the Wedbush Healthcare Conference on Wednesday, August 12, 2015 at ... and subsequent archived replay of the Company’s presentation may be accessed via the investor ...
(Date:8/3/2015)... ... 2015 , ... A July 13 article from The Daily Mail titled ... Painkiller That Can Last 'For Five Weeks'" discusses the use of stem cells ... showed that harvesting stem cell-rich bone marrow from the hip, known as bone marrow ...
(Date:8/3/2015)... ... 2015 , ... Constantin Vasilica, 48 from Romania wanted to have an alternative ... many years of suffering and using medications with strong side effects. This had already ... extra time off or wait longer hours in the waiting rooms. Instead, he went ...
Breaking Medicine News(10 mins):Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 2Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3
... at Moffitt Cancer Center in Tampa, Fla., have found ... patients with gastrointestinal malignancies to higher body mass index ... negative outcomes, there was no such link. They concluded ... or esophageal cancer patient survival. Their study was ...
... News) -- The common cold appears to increase the ... them more sensitive, which triggers coughing, wheezing and breathlessness, ... especially vulnerable to this virus-induced coughing, said the researchers ... known as transient receptor potential (TRP) receptors. ...
... boys rated reading more valuable as an activity after ... new study. The findings come from a study ... and who participated in a reading improvement class that ... authors, Dara Williams-Rossi, Southern Methodist University, Dallas. The ...
... What happens on the day before a colonoscopy may ... Gastroenterologists at Washington University School of Medicine in ... prep for the test by cleansing their colons, doctors ... in the journal Gastrointestinal Endoscopy , the researchers ...
... Steven Reinberg HealthDay Reporter , MONDAY, March ... a novel "monoclonal antibody" lowered LDL cholesterol levels in ... percent. This new treatment could help lower levels ... who don,t respond to the commonly prescribed cholesterol-lowering drugs ...
... By Steven Reinberg HealthDay Reporter , MONDAY, March 26 ... with chest pain aren,t having a heart attack, but it can ... a new study finds that a special kind of CT scan ... faster than traditional methods, so patients can be sent home safely ...
Cached Medicine News:Health News:Does BMI affect post-surgical complications, survival in esophageal adenocarcinoma? 2Health News:Research Shows How Colds Lead to Coughing, Wheezing 2Health News:Middle school boys who are reluctant readers value reading more after using e-readers 2Health News:Middle school boys who are reluctant readers value reading more after using e-readers 3Health News:Poor colonoscopy prep hides pre-cancerous polyps 2Health News:Poor colonoscopy prep hides pre-cancerous polyps 3Health News:Poor colonoscopy prep hides pre-cancerous polyps 4Health News:New Injection Might Lower Tough-to-Treat Cholesterol 2Health News:New Injection Might Lower Tough-to-Treat Cholesterol 3Health News:CT Scans Can Spot Heart Trouble Fast 2Health News:CT Scans Can Spot Heart Trouble Fast 3
3 Gently Curved Prongs, 5mm extended, Stainless Steel Tips; with titanium handle....
Straight shafts with fine Pierse type tips on a 5mm platform; In Titanium...
Straight shaft; a 5mm platform with 0.3mm 1x2 teeth; In Titanium....
Straight Shafts with 0.2mm 1X2 Teeth, 5mm Tying Platform; In Titanium....
Medicine Products: